{"result": "(\"entity\"<|>HYPERTIROIDISM<|>EVENT<|>Hyperthyroidism is a condition characterized by an overproduction of thyroid hormones, leading to various symptoms and requiring careful management, especially during pregnancy and lactation.)\n##\n(\"entity\"<|>NATIONWIDE SURVEYS<|>EVENT<|>Nationwide surveys conducted by the Japan Thyroid Association and Japan Endocrine Society aim to gather data on thyroid storm and related conditions to improve diagnosis and treatment.)\n##\n(\"entity\"<|>CLINICAL ENDOCRINOLOGY<|>ORGANIZATION<|>Clinical Endocrinology is a journal that publishes research and clinical guidelines related to endocrine disorders, including thyroid conditions.)\n##\n(\"relationship\"<|>HYPERTIROIDISM<|>THYROID STORM<|>Hyperthyroidism can lead to thyroid storm if not managed properly, making it a critical condition to monitor<|>7)\n##\n(\"relationship\"<|>NATIONWIDE SURVEYS<|>JAPAN THYROID ASSOCIATION<|>The Japan Thyroid Association conducts nationwide surveys to gather data on thyroid conditions, including thyroid storm<|>6)\n##\n(\"relationship\"<|>NATIONWIDE SURVEYS<|>JAPAN ENDOCRINE SOCIETY<|>The Japan Endocrine Society collaborates on nationwide surveys to improve understanding and management of thyroid disorders<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: • Carroll R, Matfin G. Endocrine and metabolic emergencies: thyroid storm. Ther Adv Endocrinol Metab. 2010;1:139-45.\n                                                                                                                                                         • Isozaki O, Satoh T, Wakino S, Suzuki A, Iburi T, Tsuboi K, et al. Treatment and management of thyroid storm: analysis of the nationwide\n         C es falsa.                                                                                                                                       surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic\n                                                                                                                                                           criteria and nationwide surveys for thyroid storm. Clin Endocrinol (Oxf). 2016;8:912-8.\n         Finalmente, la última afirmación es cierta. En efecto, debido a que la resistencia a hormo-                                                     • Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, et al. 2016 Guidelines for the management of thyroid storm from The Japan\n         nas tiroideas es siempre parcial, la administración exógena de hormonas tiroideas puede                                                           Thyroid Association and Japan Endocrine Society (First edition). Endocr J. 2016;63:1025-64.\n         reducir los niveles de TSH. Sin embargo, esta reducción es parcial y variable según la dosis\n         de hormona tiroidea administrada y no es específica de la T3.                                                                                   ¿Cuál de los enunciados siguientes es cierto sobre el hipertiroidismo\n                                                                                                                                                     19\n         Referencias:                                                                                                                                    y el embarazo/lactancia?\n         • Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau J-L.. 2013 European Thyroid Association Guidelines for the Diagnosis and\n           Treatment of Thyrotropin-Secreting Pituitary Tumors. Eur Thyroid J. 2013;2:76-82.                                                             A. En la lactancia natural o materna no se puede dar tiamazol a la madre por el elevado\n         • Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, et al. Sex hormone-binding globulin measurement in patients\n           with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.          riesgo de hipotiroidismo en el lactante.\n           J Clin Endocrinol Metab. 1990;71:19-25.                                                                                                       B. El hipertiroidismo subclínico durante el embarazo no suele necesitar tratamiento.\n         • Olateju TO, Vanderpump MP. Thyroid hormone resistance. Ann Clin Biochem. 2006;43:431-40.\n         • Singhn BK, Yen PM. A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ            C. Durante el embarazo es muy importante para la salud maternofetal mantener unos\n           isoforms. Clin Diabetes Endocrinol. 2017;3:8.\n                                                                                                                                                             niveles normales de TSH (iguales a los de las mujeres adultas no embarazadas).\n                                                                                                                                                         D.  En el primer trimestre del embarazo no se debe utilizar propiltiouracilo (PTU).\n     18  En el tratamiento de la tormenta tiroidea, ¿cuál de los siguientes medicamentos\n         no se ha mostrado útil?                                                                                                                         COMENTARIO\n         A. Tiamazol.                                                                                                                                    Tanto el tiamazol como el propiltiouracilo (PTU) se detectan en la leche de mujeres hiperti-\n         B. Colestiramina.                                                                                                                               roideas tratadas con estos fármacos. Sin embargo, lo hacen en cantidades muy pequeñas.\n         C. Solución de lugol.                                                                                                                           En efecto, se ha calculado que únicamente el 0,1-0,2% del tiamazol ingerido se excreta por\n         D.  Todos pueden ser útiles.                                                                                                                    la leche materna. Esto supone que de una dosis de 40 mg de tiamazol pasarían al lactante\n                                                                                                                                                         70 µg. Tampoco se          ha visto ninguna alteración ni en las pruebas de función tiroidea ni en el\n                                                                                                                                                         desarrollo neurocognitivo de lactantes cuyas madres tomaron tiamazol durante la lactan-\n         COMENTARIO                                                                                                                                      cia. Así pues, su utilización en la lactancia es relativamente segura, aunque se aconseja no\n         La tormenta tiroidea o crisis tirotóxica es una condición clínica infrecuente, caracterizada                                                    sobrepasar los 20 mg diarios de tiamazol (opción A falsa).\n         por clínica de hipertiroidismo exacerbada. Tiene una mortalidad apreciable, alrededor de un                                                     En cuanto a la segunda opción, es importante considerar que durante el primer trimestre\n         10% de los casos, por lo que un tratamiento enérgico y precoz es fundamental.                                                                   del embarazolos niveles de TSH disminuyen en respuesta fisiológica a la estimulación del\n         Los antitiroideos en dosis altas son los fármacos de primera elección. Se recomienda ini-                                                       receptor de la TSH por la HCG\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>JAPAN THYROID ASSOCIATION<|>ORGANIZATION<|>The Japan Thyroid Association is a professional organization focused on thyroid health and research, involved in establishing diagnostic criteria and guidelines for thyroid-related conditions.)\n##\n(\"entity\"<|>JAPAN ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Japan Endocrine Society is a professional organization that focuses on endocrine health and research, contributing to the management and treatment guidelines for endocrine disorders.)\n##\n(\"entity\"<|>THYROID STORM<|>EVENT<|>Thyroid storm is a rare but severe condition characterized by an exacerbation of hyperthyroidism symptoms, requiring urgent medical treatment to prevent mortality.)\n##\n(\"entity\"<|>TIAMAZOL<|>ORGANIZATION<|>Tiamazol is a medication used to treat hyperthyroidism, particularly in cases of thyroid storm, but its use during breastfeeding is debated due to its presence in breast milk.)\n##\n(\"entity\"<|>PROPILTIOURACILO<|>ORGANIZATION<|>Propiltiouracilo (PTU) is another medication used to manage hyperthyroidism, with specific considerations for its use during pregnancy and lactation.)\n##\n(\"entity\"<|>ENDOCR J<|>ORGANIZATION<|>Endocr J is a scientific journal that publishes research and guidelines related to endocrinology, including thyroid disorders.)\n##\n(\"entity\"<|>CLINICAL ENDOCRINOLOGY<|>ORGANIZATION<|>Clinical Endocrinology is a journal that focuses on research and clinical practices in the field of endocrinology, including thyroid health.)\n##\n(\"entity\"<|>BECK-PECCOZ P<|>PERSON<|>Beck-Peccoz P is a researcher and author involved in the study and publication of guidelines related to thyroid disorders.)\n##\n(\"entity\"<|>SATOH T<|>PERSON<|>Satoh T is a researcher and author who has contributed to the guidelines and studies on thyroid health and management.)\n##\n(\"entity\"<|>ISOZAKI O<|>PERSON<|>Isozaki O is a researcher who has worked on the treatment and management of thyroid storm and related conditions.)\n##\n(\"relationship\"<|>JAPAN THYROID ASSOCIATION<|>JAPAN ENDOCRINE SOCIETY<|>Both organizations collaborate on establishing guidelines and criteria for the diagnosis and treatment of thyroid disorders<|>7)\n##\n(\"relationship\"<|>JAPAN THYROID ASSOCIATION<|>THYROID STORM<|>The Japan Thyroid Association provides guidelines for the management of thyroid storm<|>6)\n##\n(\"relationship\"<|>JAPAN ENDOCRINE SOCIETY<|>THYROID STORM<|>The Japan Endocrine Society contributes to the management guidelines for thyroid storm<|>6)\n##\n(\"relationship\"<|>TIAMAZOL<|>THYROID STORM<|>Tiamazol is a medication used in the treatment of thyroid storm<|>8)\n##\n(\"relationship\"<|>PROPILTIOURACILO<|>THYROID STORM<|>Propiltiouracilo is a medication that may be used in the management of thyroid storm<|>8)\n##\n(\"relationship\"<|>BECK-PECCOZ P<|>JAPAN THYROID ASSOCIATION<|>Beck-Peccoz P is a contributor to the guidelines published by the Japan Thyroid Association<|>5)\n##\n(\"relationship\"<|>SATOH T<|>JAPAN THYROID ASSOCIATION<|>Satoh T has contributed to the guidelines and research published by the Japan Thyroid Association<|>5)\n##\n(\"relationship\"<|>ISOZAKI O<|>JAPAN THYROID ASSOCIATION<|>Isozaki O has worked on the treatment guidelines related to thyroid conditions under the Japan Thyroid Association<|>5)\n<|COMPLETE|>"}]}